Stock A052260 HYUNDAI BIOLAND CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials HYUNDAI BIOLAND Co.,Ltd.

Equities

A052260

KR7052260007

Personal Products

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
6,080 KRW -1.46% Intraday chart for HYUNDAI BIOLAND Co.,Ltd. -12.89% +21.84%
May. 16 HYUNDAI BIOLAND Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 HYUNDAI BIOLAND Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 237,750 315,750 366,750 258,000 201,750 149,700
Enterprise Value (EV) 1 247,656 341,672 398,787 276,570 214,225 159,645
P/E ratio 15.8 x 29.1 x -27.1 x -22.1 x 42.3 x 18.6 x
Yield 1.89% 1.66% 0.41% 0.41% 0.52% 0.7%
Capitalization / Revenue 2.36 x 2.97 x 4.13 x 2.51 x 2.03 x 1.47 x
EV / Revenue 2.46 x 3.21 x 4.49 x 2.69 x 2.16 x 1.57 x
EV / EBITDA 10.7 x 16.3 x -138 x 14.4 x 13.9 x 12 x
EV / FCF -60.7 x -24.5 x 83.4 x 18.7 x 111 x -104 x
FCF Yield -1.65% -4.09% 1.2% 5.36% 0.9% -0.96%
Price to Book 1.6 x 2.03 x 2.67 x 2.06 x 1.56 x 1.1 x
Nbr of stocks (in thousands) 30,000 30,000 30,000 30,000 30,000 30,000
Reference price 2 7,925 10,525 12,225 8,600 6,725 4,990
Announcement Date 3/4/19 3/2/20 3/10/21 3/14/22 3/10/23 3/12/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 100,589 106,311 88,899 102,802 99,154 101,691
EBITDA 1 23,240 20,961 -2,886 19,219 15,383 13,349
EBIT 1 17,056 14,460 -8,861 10,658 9,055 7,048
Operating Margin 16.96% 13.6% -9.97% 10.37% 9.13% 6.93%
Earnings before Tax (EBT) 1 16,034 12,995 -17,921 -15,165 6,844 9,992
Net income 1 15,047 10,849 -13,545 -11,686 4,764 8,056
Net margin 14.96% 10.2% -15.24% -11.37% 4.8% 7.92%
EPS 2 501.6 361.6 -451.5 -389.5 158.8 268.5
Free Cash Flow 1 -4,077 -13,967 4,779 14,826 1,937 -1,540
FCF margin -4.05% -13.14% 5.38% 14.42% 1.95% -1.51%
FCF Conversion (EBITDA) - - - 77.14% 12.59% -
FCF Conversion (Net income) - - - - 40.65% -
Dividend per Share 2 150.0 175.0 50.00 35.00 35.00 35.00
Announcement Date 3/4/19 3/2/20 3/10/21 3/14/22 3/10/23 3/12/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 9,906 25,922 32,037 18,570 12,475 9,945
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.4262 x 1.237 x -11.1 x 0.9662 x 0.811 x 0.745 x
Free Cash Flow 1 -4,077 -13,967 4,779 14,826 1,937 -1,540
ROE (net income / shareholders' equity) 10.5% 7.12% -9.25% -8.9% 3.74% 6.07%
ROA (Net income/ Total Assets) 5.77% 4.49% -2.79% 3.7% 3.24% 2.45%
Assets 1 260,823 241,408 485,133 -316,141 146,843 329,334
Book Value Per Share 2 4,964 5,191 4,574 4,178 4,310 4,533
Cash Flow per Share 2 685.0 477.0 346.0 491.0 255.0 453.0
Capex 1 12,807 15,951 6,041 2,261 3,782 5,767
Capex / Sales 12.73% 15% 6.8% 2.2% 3.81% 5.67%
Announcement Date 3/4/19 3/2/20 3/10/21 3/14/22 3/10/23 3/12/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Cosmetics & Perfumes

1st Jan change Capi.
HYUNDAI BIOLAND CO.,LTD. Stock HYUNDAI BIOLAND Co.,Ltd.
+21.84% 134M
KAO CORPORATION Stock Kao Corporation
+18.78% 20.41B
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 19.12B
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
+18.02% 12.78B
COTY INC. Stock Coty Inc.
-15.06% 9.11B
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+27.24% 8.31B
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+9.08% 5.91B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
-8.58% 4.15B
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-17.45% 3.81B
INTERPARFUMS Stock Interparfums
-3.57% 3.64B
Cosmetics & Perfumes
  1. Stock Market
  2. Equities
  3. A052260 Stock
  4. Financials HYUNDAI BIOLAND Co.,Ltd.